VAGINAL MICROBIOCENOSIS: CLINICAL ASPECTS, WAYS OF CORRECTION AND PREVENTION OF ABNORMALITIES


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To carry out a systems analysis of the data available in the current literature on possible abnormalities in the composition and properties of vaginal microbiocenosis. To consider the clinical aspects of different vaginal dysbioses in reproductive-aged women. Material and methods. The review includes the data of foreign and Russian papers published in the past 20 years. Results. The paper analyzes the relationship between the microecological system of the intestine and that of the genital tract in women. It also shows that it is possible to correct the vaginal and intestinal microflora and to prevent its abnormalities with probiotics. Conclusion. The efficacy of a combination of the probiotic microorganisms Lactobacillus acidophilus (LA-5) and Bifidobacterium animalis subsp. lactis (BB-12) was evaluated; their positive effect on the body’s microecosystems was established.

Full Text

Restricted Access

About the authors

N. V Krasikov

Email: medman@ogyn.ru
obstetrician-gynecologist, Odintsovo Central District Hospital Russia, Moscow region, Odintsovo, M. Birjuzova str. 7

Yu. A Filyaeva

Email: medwoman@ogyn.ru
MD, an obstetrician-gynecologist, Center for Fetal Medicine Russia, Moscow, Myasnitskaya str. 32, bld. 1

G. F Totchiev

Email: 23george@mail.ru
MD, Professor of Obstetrics and Gynaecology with Course of Perinatology, People Friendship University of Russia. Russia, Moscow, Miklukho-Maklaya str. 8

References

  1. Bilardi J.E., Walker S., Temple-Smith M., McNair R., Mooney-Somers J., Bellhouse C. et al. The burden of bacterial vaginosis: women’s experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis. PLoS One. 2013; 8(9): e74378. doi: 10.1371/journal.pone.0074378. eCollection 2013.
  2. Africa C.W.J., Nel J., Stemmet M. Anaerobes and bacterial vaginosis in pregnancy: virulence factors contributing to vaginal colonisation. Int. J. Environ. Res. Public Health. 2014; 11(7): 6979-7000. doi: 10.3390/ijerph110706979.
  3. Воронова Ю.В. Дисбиоз влагалища: современные аспекты диагностики и лечения. Дальневосточный медицинский журнал. 2014; 2: 127-31.
  4. Гродницкая Е.Э., Латышкевич О.А. Микробиоценоз влагалища и пути его коррекции у женщин с невынашиванием беременности и преждевременными родами в анамнезе. Российский вестник акушера-гинеколога. 2014; 14(1): 81-3. [Grodnitskaya E.E., Latyishkevich O.A. Microbiocenosis vagina and ways of its correction in women with miscarriage and premature birth history. Rossiyskiy vestnik akushera-ginekologa. 2014; 14(1): 81-3. (in Russian)]
  5. Hay P.E., Morgan D.J., Ison C.A., Bhide S.A., Romney M., McKenzie P. et al. A longitudinal study of bacterial vaginosis during pregnancy. Br. J. Obstet. Gynaecol. 1994; 101(12): 1048-53.
  6. Hillier S.L., Nugent R.P., Eschenbach D.A., Krohn M.A., Gibbs R.S., Martin D.H. et al. Association between bacterial vaginosis and preterm delivery of a low-birthweight infant. The Vaginal Infections and Prematurity Study Group. N. Engl. J. Med. 1995; 333(26): 1737-42.
  7. Calleri L., Porcelli A., Gallello D., Taccani C., Surico N. Bacterial vaginosis and premature membranes rupture: an open study, Preliminary data. Minerva Ginecol. 1997; 49(1-2): 19-23.
  8. Уварова Е.В., Анкирская А. С., Григоренко Ю.П., Кумыкова З.Х. Эффективность терапии бактериального вагиноза у женщин вне беременности (результаты многоцентрового исследования). Акушерство и гинекология. 2010; 1: 52-6. [Uvarova E.V., Ankirskaya A.S., Grigorenko Yu.P., Kumyikova Z.H. The effectiveness of treatment of bacterial vaginosis in nonpregnant women (results of a multicenter study). Akusherstvo i Ginekologiya/ Obstetrics and Gynecology. 2010; (1): 52-6. (in Russian)]
  9. Mastromarino P., Hemalatha R., Barbonetti A., Cinque B., Cifone M.G., Tammaro F. Biological control of vaginosis to improve reproductive health. Indian J. Med. Res. 2014;140(Suppl.): S91-7.
  10. Wiesenfeld H.C., Hillier S.L., Krohn M.A., Landers D.V., Sweet R.L. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin. Infect. Dis. 2003; 36(5): 663-8.
  11. van Oostrum N., De Sutter P., Meys J., Verstraelen H. Risks associated with bacterial vaginosis in infertility patients: a systematic review and meta-analysis. Hum. Reprod. 2013; 28(7):1809-15. doi: 10.1093/humrep/det096.
  12. Eckert L.O., Moore D.E., Patton D.L., Agnew K.J., Eschenbach D.A. Relationship of vaginal bacteria and inflammation with conception and early pregnancy loss following in-vitro fertilization. Infect. Dis. Obstet. Gynecol. 2003; 11(1): 11-7.
  13. Atashili J., Poole C., Ndumbe P.M., Adimora A.A., Smith J.S. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS. 2008; 22(12): 1493-501. doi: 10.1097/QAD.0b013e3283021a37.
  14. Martin H.L., Richardson B.A., Nyange P.M., Lavreys L., Hillier S.L., Chohan B. et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J. Infect. Dis. 1999; 180(6): 1863-8.
  15. Lu H., Jiang P.C., Zhang X.D., Hou W.J., Wei Z.H., Lu J.Q. et al. Characteristics of bacterial vaginosis infection in cervical lesions with high risk human papillomavirus infection. Int. J. Clin. Exp. Med. 2015; 8(11): 21080-8.
  16. de Castro-Sobrinho J.M., Rabelo-Santos S.H., Fugueiredo-Alves R.R., Derchain S., Sarian L.O., Pitta D.R. et al. Bacterial vaginosis and inflammatory response showed association with severity of cervical neoplasia in HPV-positive women. Diagn. Cytopathol. 2016; 44(2): 80-6. doi: 10.1002/dc.23388.
  17. Peres A.L., Camarotti J.R., Cartaxo M., Alencar N., Stocco R.C., Beçak W. et al. Molecular analysis and conventional cytology: association between HPV and bacterial vaginosis in the cervical abnormalities of a Brazilian population. Genet. Mol. Res. 2015; 14(3): 9497-505. doi: 10.4238/2015.August.14.13.
  18. Gillet E., Meys J.F., Verstraelen H., Verhelst R., De Sutter P., Temmerman M. Association between bacterial vaginosis and cervical intraepithelial neoplasia: systematic review and meta-analysis. PLoS One. 2012; 7(10): e45201. doi: 10.1371/journal.pone.0045201.
  19. Verstraelen H., Verhelst R., Vaneechoutte M., Temmerman M. The epidemiology of bacterial vaginosis in relation to sexual behaviour. BMC Infect. Dis. 2010; 10: 81. doi: 10.1186/1471-2334-10-81.
  20. Fethers K.A., Fairley C.K., Hocking J.S., Gurrin L.C., Bradshaw C.S. Sexual risk factors and bacterial vaginosis: a systematic review and meta-analysis. Clin. Infect. Dis. 2008; 47(11): 1426-35. doi: 10.1086/592974.
  21. Marrazzo J.M. Interpreting the epidemiology and natural history of bacterial vaginosis: are we still confused? Anaerobe. 2011; 17(4): 186-90. doi: 10.1016/j. anaerobe.2011.03.016.
  22. Swidsinski A., Mendling W., Loening-Baucke V., Swidsinski S., Dörffel Y., Scholze J. et al. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am. J. Obstet. Gynecol. 2008; 198(1): 97. e1-6.
  23. Swidsinski A., Verstraelen H., Loening-Baucke V., Swidsinski S., Mendling W., Halwani Z. Presence of a polymicrobial endometrial biofilm in patients with bacterial vaginosis. PLoS One. 2013; 8(1): e53997. doi: 10.1371/journal. pone.0053997.
  24. Donders G.G. Definition and classification of abnormal vaginal flora. Best Pract. Res. Clin. Obstet. Gynaecol. 2007; 21(3): 355-73.
  25. Donders G.G. Microscopy of the bacterial flora on fresh vaginal smears. Infect. Dis. Obstet. Gynecol. 1999; 7(4): 177-9.
  26. Martinez-Peña M.D., Castro-Escarpulli G., Aguilera-Arreola M.G. Lactobacillus species isolated from vaginal secretions of healthy and bacterial vaginosis-intermediate Mexican women: a prospective study. BMC Infect. Dis. 2013; 13: 189. doi: 10.1186/1471-2334-13-189.
  27. Slover C.M., Danzinger L. Lactobacillus: a review. Clin. Microbiol. Newsl. 2008; 30: 23-7. doi: 10.1016/j.clinmicnews.2008.01.006.
  28. Ljungh A., Wadström T. Lactobacillus molecular biology: from genomics to probiotics. Norfolk, UK: Caister Academic Press; 2009.
  29. Hay P.E., Lamont R.F., Taylor-Robinson D., Morgan D.J., Ison C., Pearson J. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. Br. Med. J. 1994; 308: 295-8.
  30. Platz-Christensen J.J., Larsson P.G., Sundstrom E., Wiqvist N. Detection of bacterial vaginosis in wet mount, Papanicolaou stained vaginal smears and in Gram stained smears. Acta Obstet. Gynecol. Scand. 1995; 74: 67-70.
  31. Yamamoto T., Zhou X., Williams C.J., Hochwalt A., Forney L.J. Bacterial populations in the vaginas of healthy adolescent women. J. Pediatr. Adolesc. Gynecol. 2009; 22(1): 11-8. doi: 10.1016/j.jpag.2008.01.073.
  32. Gorgos L.M., Sycuro L.K., Srinivasan S., Fiedler T.L., Morgan M.T., Balkus J.E. et al. Relationship of specific bacteria in the cervical and vaginal microbiotas with cervicitis. Sex. Transm. Dis. 2015; 42(9): 475-81. doi: 10.1097/ OLQ.0000000000000318.
  33. Мелкумян А.Р., Припутневич Т.В., Анкирская А. С., Трофимов Д.Ю., Муравьева В.В., Муллабаева С.М., Завьялова М.Г. Видовой состав лактобактерий при различном состоянии микробиоты влагалища у беременных. Клиническая микробиология и антимикробная химиотерапия. 2013; 15(1): 72-9. [Melkumyan A.R., Priputnevich T.V., Ankirskaya A.S., Trofimov D.Yu., Muraveva V.V., Mullabaeva S.M., Zavyalova M.G. Species composition of lactic acid bacteria under various conditions of vaginal microbiota in pregnant women. Klinicheskaya mikrobiologiya i antimikrobnaya himioterapiya. 2013; 15(1): 72-9. (in Russian)]
  34. Карапетян Т.Э., Муравьева В.В., Тютюнник В.Л., Анкирская А.С. Оценка эффективности лечения оппортунистических инфекций влагалища у беременных. Медицинский совет. 2013; 4: 104-7. [Karapetyan T.E., Muraveva V.V., Tyutyunnik V.L., Ankirskaya A.S. Evaluating the effectiveness of treatment of opportunistic infections of the vagina in pregnancy. Meditsinskiy sovet. 2013; 4: 104-7. (in Russian)]
  35. Witkin S.S., Linhares I.M., Giraldo P., Ledger W.J. An altered immunity hypothesis for the development of symptomatic bacterial vaginosis. Clin. Infect. Dis. 2007; 44(4): 554-7.
  36. Мозговая Е.В., Талалаева Н.Е., Маругина Е.А., Рыбина Е.В. Антимикробная терапия неспецифических воспалительных заболеваний нижних отделов половых путей у беременных препаратом Метромикон-Нео. Доктор Ру. Гинекология Эндокринология. 2014; 12 1-9. [Mozgovaya E.V., Talalaeva N.E., Marugina E.A., Ryibina E.V. Antimicrobial therapy of nonspecific inflammatory diseases of the lower genital tract of pregnant drug Neo-Metromikon. Doktor Ru. Ginekologiya Endokrinologiya. 2014; 12 1-9. (in Russian)]
  37. Hawrelak J.A., Myers S.P. The causes of intestinal dysbiosis: a review. Altern. Med. Rev. 2004; 9(2): 180-97.
  38. Holzapfel W.H., Haberer P., Snel J., Schillinger U., Huisin’t Veld J.H. Overview of gut flora and probiotics. Int. J. Food Microbiol. 1998; 41: 85-101.
  39. Noack J., Kleessen B., Proll J., Dongowski G., Blaut M. Dietary guar gum and pectin stimulate intestinal microbial polyamine synthesis in rats. J. Nutr. 1998; 128: 1385-91.
  40. Gibson G.R., Roberfroid M.B. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 1995; 125: 1401-12.
  41. Savage D.C. Microbial ecology of the gastrointestinal tract. Annu. Rev. Microbiol. 1977; 31: 107-33.
  42. Bengmark S. Probiotics and prebiotics in prevention and treatment of gastrointestinal diseases. Gastroenterol. Int. 1998; 11: 4-7.
  43. Macfarlane G.T., Macfarlane S. Human colonic microbiota: ecology, physiology and metabolic potential of intestinal bacteria. Scand. J. Gastroenterol. 1997; 32 (Suppl. 222): 3-9. doi: 10.1080/00365521.1997.11720708.
  44. Bengmark S. Ecological control of the gastrointestinal tract. The role of probiotic flora. Gut. 1998; 42: 2-7.
  45. Bailey M.T., Coe C.L. Maternal separation disrupts the integrity of the intestinal microflora in infant rhesus monkeys. Dev. Psychobiol. 1999; 35: 146-55.
  46. Lenz H.J., Druge G. Neurohormonal pathways mediating stress-induced inhibition of gastric acid secretion in rats. Gastroenterology. 1990; 98: 1490-2.
  47. Lenz H.J., Burlage M., Raedler A., Greten H. Central nervous system effects of corticotropin-releasing factor on gastrointestinal transit in the rat. Gastroenterology. 1988; 94: 598-602.
  48. Lenz H.J. Regulation of duodenal bicarbonate secretion during stress by corticotropinreleasing factor and beta-endorphin. Proc. Natl. Acad. Sci. USA. 1989; 86: 1417-20.
  49. Lizko N.N. Stress and intestinal microflora. Nahrung. 1987; 31: 443-7.
  50. Hentges D.J. Gut flora and disease resistance. In: Fuller R., ed. Probiotics: the scientific basis. London: Chapman and Hall; 1992: 87-110.
  51. Macfarlane G.T., Gibson G.R. Metabolic activities of the normal colonic flora. In: Gibson S.A.W., ed. Human health: the contribution of microorganisms. London: Springer-Verlag; 1994: 17-53.
  52. Donovan P. Bowel toxemia, permeability and disease: new information to support an old concept. In: Pizzorno J., Murray M., eds. Textbook of natural medicine. Seattle, WA: Bastyr College Publications; 1992: 1-7.
  53. Holst E. Reservoir of four organisms associated with bacterial vaginosis suggests lack of sexual transmission. J. Clin. Microbiol. 1990; 28(9): 2035-9.
  54. Antonio M.A., Rabe L.K., Hillier S.L. Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis. J. Infect. Dis. 2005; 192(3): 394-8.
  55. Swidsinski A., Dörffel Y., Loening-Baucke V., Mendling W., Schilling J., Patterson J.L. et al. Dissimilarity in the occurrence of Bifidobacteriaceae in vaginal and perianal microbiota in women with bacterial vaginosis. Anaerobe. 2010; 16(5): 478-82. doi: 10.1016/j.anaerobe.2010.06.011.
  56. Cribby S., Taylor M., Reid G. Vaginal microbiota and the use of probiotics. Interdiscip. Perspect. Infect. Dis. 2008; 2008: 256490. doi: 10.1155/2008/256490.
  57. Reid G., Charbonneau D., Erb J., Kochanowski B., Beuerman D., Poehner R. et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol. Med. Microbiol. 2003; 35(2): 131-4.
  58. Reid G., Bruce A.W., Fraser N., Heinemann C., Owen J., Henning B. Oral probiotics can resolve urogenital infections. FEMS Immunol. Med. Microbiol. 2001; 30(1): 49-52.
  59. Morelli L., Zonenenschain D., Del Piano M., Cognein P. Utilization of the intestinal tract as a delivery system for urogenital probiotics. J. Clin. Gastroenterol. 2004; 38(6, Suppl.): S107-10.
  60. Gardiner G.E., Heinemann C., Bruce A.W., Beuerman D., Reid G. Persistence of Lactobacillus fermentum RC-14 and Lactobacillus rhamnosus GR-1, but not L. rhamnosus GG in the human vagina as demonstrated by randomly amplified polymorphic DNA. Clin. Diagn. Lab. Immunol. 2002; 9(1): 92-6.
  61. Reid G., Beuerman D., Heinemann C., Bruce A.W. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol. Med. Microbiol. 2001; 32(1): 37-41.
  62. Anukam K., Osazuwa E., Ahonkhai I., Ngwu M., Osemene G., Bruce A.W. et al. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes Infect. 2006; 8(6): 1450-4.
  63. Vicariotto F., Del Piano M., Mogna L., Mogna G. Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study. J. Clin. Gastroenterol. 2012; 46(Suppl.): S73-80. doi: 10.1097/MCG.0b013e3182684d71.
  64. De Seta F., Parazzini F., De Leo R., Banco R., Maso G.P., De Santo D. et al. Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: a retrospective comparative study. Eur. J. Obstet. Gynecol. Reprod. Biol. 2014; 182: 136-9. doi: 10.1016/j.ejogrb.2014.09.018
  65. Huang H., Song L., Zhao W. Effects of probiotics for the treatment of bacterial vaginosis in adult women: a meta-analysis of randomized clinical trials. Arch. Gynecol. Obstet. 2014; 289(6): 1225-34. doi: 10.1007/s00404-013-3117-0.
  66. McMillan A., Dell M., Zellar M.P., Cribby S., Martz S., Hong E. et al. Disruption of urogenital biofilms by lactobacilli. Colloids Surf B Biointerfaces. 2011; 86(1): 58-64. doi: 10.1016/j.colsurfb.2011.03.016.
  67. Machado D., Castro J., Palmeira-de-Oliveira A., Martinez-de-Oliveira J., Cerca N. Bacterial vaginosis biofilms: challenges to current therapies and emerging solutions. Front. Microbiol. 2016; 6: 1528. doi: 10.3389/fmicb.2015.01528. eCollection 2015.
  68. Lee S.J., Shim Y.H., Cho S.J., Lee J.W. Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatr. Nephrol. 2007; 22(9): 1315-20.
  69. Ушкалова Е.А., Гущина Ю.Ш. Линекс Форте в профилактике и лечении желудочно-кишечных заболеваний. Терапевтический архив. 2015; 87(12): 138-44. [Ushkalova E.A., Guschina Yu.Sh. Linex Forte in the prevention and treatment of gastrointestinal diseases. Terapevticheskiy arhiv. 2015; 87(12): 138 44. (in Russian)]
  70. Андреева И.В., Стецюк О.У. Эффективность и безопасность комбинации Lactobacillus acidophilus LA-5 и Bifidobacterium lactis BB-12 в гастроэнтерологии, педиатрии и аллергологии. Клиническая микробиология и антимикробная химиотерапия. 2016; 18(2): 113-24. [Andreeva I.V., Stetsyuk O.U. Efficacy and safety of a combination of Lactobacillus acidophilus LA-5 and Bifidobacterium lactis BB-12 in gastroenterology, pediatrics and allergy. Klinicheskaya mikrobiologiya i antimikrobnaya himioterapiya. 2016; 18(2): 113 24. (in Russian)]
  71. Михайленко Е.Л. Клинико-терапевтические аспекты воспалительных заболеваний наружных гениталий у девочек, больных острыми кишечными инфекциями: дисс.. канд. мед. наук. М.; 2010. 138с. [Mikhaylenko E.L. Clinical and therapeutic aspects of inflammatory diseases of the external genitalia in girls with acute intestinal infections. Diss. Moscow; 2010. 138p. (in Russian)]

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies